UM  > 中華醫藥研究院
Monitoring drug research on clinical neurology in China: An analysis of institutional leaders and community themes
Ka Weng Si Tou1; Jianbo Wan1; Marvin S.H. Mak2; Yifan Han2; Yuanjia Hu1
2017
Source PublicationInnovation Value Chain of Chinese Pharmaceuticals
Author of SourceYitao Wang, Yuanjia Hu, Albert Wai-Kit Chan
Publication PlaceWhitestone, New York
PublisherUnited States-China Intellectual Property Institute Inc.
Pages53-72
Abstract

Background: The discovery of new neurological therapeutic agents is one of the most active areas of research and development (R&D) in China. This paper intends to find out the leading Chinese institutes in neurological drug research based on co-authorship and to reveal the research directions of identified communities.

Methods: 629 papers published during 2008-2013 under the subject categories “Pharmacology & Pharmacy” or “Integrative & Complementary Medicine” combining with “Clinical Neurology”, containing a Chinese institute in the author’s address were retrieved from the Science Citation Index Expanded (SCIE) Database. We used research collaboration associations to define an institutional network and network communities to identify the research topics of each community.

Results: Key participants in the network are mainly located in Shanghai and Taiwan, while the ones from Hong Kong are acting as a bridge for knowledge exchange between mainland China and Taiwan. These sample articles cover a wide range of topics, in which depression, schizophrenia, serotonin and genetic polymorphism are the most extensively studied issues.

Conclusions: Collaborations across regions and between academia, clinics, and industry need to be further enhanced. Meanwhile, this study may provide guidance for researchers, clinicians, and investors to cooperate and in turn improve efficiency in drug discovery process. 

KeywordNeurological Drugs Thematic Analysis Greater China Publications Research Collaboration Networks
Language英语
ISBN978-0-9862198-4-9
Fulltext Access
Document TypeBook chapter
CollectionInstitute of Chinese Medical Sciences
Affiliation1.State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macau SAR, China
2.Department of Applied Biology and Chemical Technology, Institute of Modern Chinese Medicine, the Hong Kong Polytechnic University, Hung Hom, Hong Kong, China
First Author AffilicationInstitute of Chinese Medical Sciences
Recommended Citation
GB/T 7714
Ka Weng Si Tou,Jianbo Wan,Marvin S.H. Mak,et al. Monitoring drug research on clinical neurology in China: An analysis of institutional leaders and community themes. Whitestone, New York:United States-China Intellectual Property Institute Inc.,2017:53-72.
Files in This Item:
There are no files associated with this item.
Related Services
Recommend this item
Bookmark
Usage statistics
Export to Endnote
Google Scholar
Similar articles in Google Scholar
[Ka Weng Si Tou]'s Articles
[Jianbo Wan]'s Articles
[Marvin S.H. Mak]'s Articles
Baidu academic
Similar articles in Baidu academic
[Ka Weng Si Tou]'s Articles
[Jianbo Wan]'s Articles
[Marvin S.H. Mak]'s Articles
Bing Scholar
Similar articles in Bing Scholar
[Ka Weng Si Tou]'s Articles
[Jianbo Wan]'s Articles
[Marvin S.H. Mak]'s Articles
Terms of Use
No data!
Social Bookmark/Share
All comments (0)
No comment.
 

Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.